Unitree Printed the IPO Pricing Lesson Nobody Wanted

The stock opened at 1,100 yuan. Four trading sessions later it closed at 603 yuan. That is not a market correction. That is price discovery arriving four days late and charging admission on the way in.

Unitree Robotics debuted on the STAR Market on August 19, priced at 150.80 yuan per share. By August 24, the stock had closed at 603.08 yuan, a drawdown of more than 40% from its opening price. That move wiped out roughly $29.8 billion in market value.

The consensus read is: volatile market, overhyped sector, one-off correction. That read is wrong, and believing it costs you money.

The Mechanism Failed, Not the Company

Unitree is a real business. The company reported 2025 net profit of 591 million yuan on revenue of 1.7 billion yuan with a 60% gross margin. Profitable hardware with a real growth curve. Most robotics startups would trade their entire cap table for that filing.

What collapsed was the narrative, not the business.

The company generated 868 million yuan in humanoid robot revenue in 2025, but 73.6% came from research and education customers, while industrial applications accounted for just 9.01%. Within that industrial slice, enterprise reception and tour-guide use accounts for 50% to 70%, with intelligent manufacturing and intelligent inspection making up the rest.

The narrative sold to retail on debut day was an AGI robotics platform displacing factory labor at scale. The prospectus described a profitable education hardware company with a growing but still-early industrial TAM. Those are two different companies at two different multiples. At offering terms, Unitree's implied a multiple of 219 times 2025 earnings and 36 times revenue. The opening valuation approached 262 times revenue.

Retail bought the narrative. Gravity corrected it.

Translation: the company buried its own best news in a filing so that a bigger headline number was possible on day one.

There is also a structural explanation that every operator and investor in this sector needs to internalize. The STAR Market's daily price limit does not apply on the first five trading days after an IPO. With only 7.44% of shares freely floating, the stock surged 629% on debut before rapidly cooling. A 7.44% float with no price limit is not a market. It is a pressure cooker. Trading volume on debut day reached approximately 23.2 billion yuan, a figure that exceeds Unitree's entire 2025 annual revenue several times over.

Additionally, first-quarter 2026 adjusted net profit fell 52.55% year-on-year, and operating cash flow dropped 85.65%. Founder Wang Xingxing extended his timeline for humanoid robot commercialization from "as early as 1-2 years" to "as early as 2-3 years." That revision, arriving alongside an IPO, is not the kind of thing retail investors parse in real time.

What Every Robotics Founder Watched Happen

Roland Berger forecasts that more than 30 robot and core component makers will go public by 2026. China has become home to more than 150 humanoid robot companies. Every one of them with an IPO roadmap just watched retail investors lose 40% in four days on the sector's most credible debut.

The pattern points to a repricing event, not a single-company stumble. A gauge of humanoid robot stocks has fallen about 12% this year after registering a 47% gain in 2025 and is trading at about 40 times forward earnings, compared with about 14 times for the CSI 300. Unitree's collapse is the live proof that those multiples will not survive contact with a public float.

If the next Chinese robotics IPO prices at a 30-40% discount to Unitree's opening valuation, the sector has mechanically reset. If it prices in line or higher, Shanghai has learned nothing and the correction that follows will be larger. Either way, the VC who modeled a Q4 2024 exit multiple off Unitree's opening tick is now rebuilding that spreadsheet from scratch.

The business in Hangzhou is fine. The price that got put on it in the first hour was not. Confusing the two is how you get the next one wrong.

What to watch: The next robotics IPO to price on the STAR Market and whether underwriters discount aggressively relative to Unitree's open. Secondary sales by early Unitree shareholders below the $36B level, which would signal margin concern beyond narrative correction. Any CSRC response on float requirements or debut-day price guidance for high-profile tech listings. And Wang Xingxing's commercialization timeline: if it moves again, the multiple moves with it.